Starbuck Protein Bistro Box, 6.80 oz. package, UPC 762111881502. The Starbuck Protein Bistro Box contains the 0.5 oz. single-serve H...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (Salmonella contamination). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0139-2013.
The 0.5 oz. single-serve Honey Peanut Butter squeeze packs in the Starbuck Protein Bistro Boxes containing peanut that has a potential to be contaminated with Salmonella.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0139-2013.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Gretchen's Shoebox Express or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0139-2013.
Gretchen's Shoebox Express
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Gretchen's Shoebox Express Recall FAQ
Gretchen's Shoebox Express is the subject of a dairy safety report: Starbuck Protein Bistro Box, 6.80 oz. package, UPC 762111881502. The Starbuck Protein Bistro Box contains the 0.5 oz. single-serve H.... The notice was published on October 2, 2012 by the U.S. Food and Drug Administration (FDA). Approximately 16 units are potentially affected.